This is an update on sarcoidosis, focusing on etiology, diagnosis, and treatment. In the area
of etiopathogenesis, we now have a better understanding of the immune response that …

Pulmonary alveolar proteinosis (PAP) is a diffuse lung disease that results from the accumulation
of lipoproteinaceous material in the alveoli and alveolar macrophages due to abnormal …

Sarcoidosis is a systemic inflammatory disease with substantial morbidity and increasing
mortality. As part of the National Heart, Lung, and Blood Institute’s workshop to better …

Developing consensus recommendations for rare diseases requires adapting the methodology
for preparing traditional guidelines for clinical practice. The most obvious difference with …

Background: The diagnosis of sarcoidosis is not standardized but is based on three major
criteria: a compatible clinical presentation, finding nonnecrotizing granulomatous inflammation …

Background The major reasons to treat sarcoidosis are to lower the morbidity and mortality
risk or to improve quality of life (QoL). The indication for treatment varies depending on which …

Introduction: A Case Control Etiology of Sarcoidosis Study (ACCESS) sarcoidosis organ
assessment instrument has been used for more than a decade to establish uniform standards …

Rationale: There have been no recent comprehensive studies of the epidemiology of sarcoidosis
in the United States. Changes in health care use have made available access to data …

The global coronavirus disease 2019 (COVID-19) pandemic, caused by severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2), has led to unprecedented social and …

Both abiotic and biotic explanations have been proposed to explain recent recurrent
nuisance/harmful algal blooms in the western basin and central basin of Lake Erie. We used two …